HIND Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline HYFM Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges Ralph Lauren RL Q1 2026 Earnings EPS Beats Estimates Amid Strong Brand Momentum Paranovus Entertainment Technology Ltd PAVS Q2 2022 Earnings Massive EPS Miss Highlights Severe Operational Challenges